Optimization of Voyager V1 (VV1) Oncolytic Virus Systemic Delivery in Combination with Cemiplimab and Ipilimumab in Patients with Melanoma and Non–small Cell Lung Cancer (NSCLC).
Journal of Clinical Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined